Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2013

01.10.2013 | Basic Science

Macular pigment in ophthalmic practice; a survey

verfasst von: Ian J. Murray, Batul Hassanali, David Carden

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Macular pigment (MP) might provide some protection against age-related eye disease, and it is now being measured in ophthalmic practice. The purpose of the survey described here was to determine the distribution of MP in a random population of patients in a typical UK ophthalmic practice.

Methods

Macular pigment optical density (MPOD) was measured in 56 patients aged 11 to 87 years, mean 52 ± 19, over a 3-month period. Typically, the test requires setting flicker thresholds for a centrally and peripherally viewed blue/green alternating target. Here we describe the results when an age-based estimate of the peripheral value is used, thus avoiding the peripheral setting. In 32 observers, a comparison was made between this and values obtained with the centre and periphery method. Information on smoking habits, iris colour, diabetic status, and ethnicity were recorded.

Results

The overall average MPOD for the population obtained with the centre-only approach for 56 individuals was 0.400 ± 0.165. The centre-only technique was an accurate predictor of values based on centre and peripheral measures, with 95 % limits of agreement of 0.137 OD units. Pearson’s correlation coefficient showed a high correlation between right and left eyes (r = 0.7 (p < 0.001)). There was a small difference between males and females that did not reach statistical significance (r = −0.22). There was a non-statistically significant age-related decline in MPOD in this particular population (r = −0.17). Dark irides were significantly associated with high MPOD (r = 0.28, p < 0.05). MPOD in Type II diabetic patients was 27 % lower than that in non-diabetics (r = 0.29, p < 0.05).

Conclusion

The technique provides similar values of MP optical density to previous reports. As with other HFP-based methods, in a small percentage of older patients, more than one measurement is required before satisfactory results are obtained.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMed Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673PubMed
3.
Zurück zum Zitat Leung IY (2008) Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degeneration. Optometry 79:266–272PubMedCrossRef Leung IY (2008) Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degeneration. Optometry 79:266–272PubMedCrossRef
4.
Zurück zum Zitat Hammond BRJ, Wooten BR, Snodderly DM (1997) Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 14:1187–1196PubMedCrossRef Hammond BRJ, Wooten BR, Snodderly DM (1997) Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 14:1187–1196PubMedCrossRef
5.
Zurück zum Zitat van der Veen RL, Berendschot TT, Makridaki M, Hendrikse F, Carden D, Murray IJ (2009) Correspondence between retinal reflectometry and a flicker-based technique in the measurement of macular pigment spatial profiles. J Biomed Opt 14:064046PubMedCrossRef van der Veen RL, Berendschot TT, Makridaki M, Hendrikse F, Carden D, Murray IJ (2009) Correspondence between retinal reflectometry and a flicker-based technique in the measurement of macular pigment spatial profiles. J Biomed Opt 14:064046PubMedCrossRef
6.
Zurück zum Zitat Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38:1802–1811PubMed Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38:1802–1811PubMed
7.
Zurück zum Zitat Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 38:537–556PubMedCrossRef Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 38:537–556PubMedCrossRef
8.
Zurück zum Zitat Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed
9.
Zurück zum Zitat Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293PubMedCrossRef Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293PubMedCrossRef
10.
Zurück zum Zitat Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867–877PubMedCrossRef Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age related macular degeneration. Br J Ophthalmol 83:867–877PubMedCrossRef
11.
Zurück zum Zitat Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134PubMedCrossRef Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134PubMedCrossRef
12.
Zurück zum Zitat Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case–control study. Invest Ophthalmol Vis Sci 42:235–240PubMed Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case–control study. Invest Ophthalmol Vis Sci 42:235–240PubMed
13.
Zurück zum Zitat Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH (2007) Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 335:755PubMedCrossRef Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH (2007) Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 335:755PubMedCrossRef
14.
Zurück zum Zitat Bone RA, Landrum JT, Guerra LH, Ruiz CA (2003) Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133:992–998PubMed Bone RA, Landrum JT, Guerra LH, Ruiz CA (2003) Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133:992–998PubMed
15.
Zurück zum Zitat Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75:216–230PubMedCrossRef Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75:216–230PubMedCrossRef
16.
Zurück zum Zitat Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S (2004) Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 79:21–27PubMedCrossRef Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S (2004) Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 79:21–27PubMedCrossRef
17.
Zurück zum Zitat Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW, Thomas C (2011) Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry 82:667 e6–680 e6CrossRef Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW, Thomas C (2011) Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry 82:667 e6–680 e6CrossRef
18.
Zurück zum Zitat Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhofer G, Schmidt-Erfurth U, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52:8174–8178PubMedCrossRef Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhofer G, Schmidt-Erfurth U, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52:8174–8178PubMedCrossRef
19.
Zurück zum Zitat Berendschot TTJM, Makridaki M, van der Veen RL, Rob LP, Parry NRA, Carden D, Murray IJ (2011) The clear (combination (of) lutein effects (on) aging retina) study; lutein supplementation improves visual acuity and night vision in early Amd; a two-centre, placebo-controlled study. Invest Ophthalmol Vis Sci 52:E-Abstract 3631 Berendschot TTJM, Makridaki M, van der Veen RL, Rob LP, Parry NRA, Carden D, Murray IJ (2011) The clear (combination (of) lutein effects (on) aging retina) study; lutein supplementation improves visual acuity and night vision in early Amd; a two-centre, placebo-controlled study. Invest Ophthalmol Vis Sci 52:E-Abstract 3631
20.
Zurück zum Zitat Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT (2013) Lutein supplementation over a 1 year period in early AMD might have a mild beneficial effect on visual acuity; the CLEAR study. Invest Ophthalmol Vis Sci 54(3):1781–1788. doi:10.1167/iovs.12-10715 PubMedCrossRef Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT (2013) Lutein supplementation over a 1 year period in early AMD might have a mild beneficial effect on visual acuity; the CLEAR study. Invest Ophthalmol Vis Sci 54(3):1781–1788. doi:10.​1167/​iovs.​12-10715 PubMedCrossRef
21.
Zurück zum Zitat Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT, Bird AC (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90:75–80PubMedCrossRef Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, Moore AT, Bird AC (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 90:75–80PubMedCrossRef
22.
Zurück zum Zitat Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B (2011) Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology 118:2203–2211PubMedCrossRef Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B (2011) Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology 118:2203–2211PubMedCrossRef
23.
Zurück zum Zitat Nolan JM, Feeney J, Kenny RA, Cronin H, O'Regan C, Savva GM, Loughman J, Finucane C, Connolly E, Meagher K, Beatty S (2012) Education is positively associated with macular pigment: the Irish Longitudinal Study on Ageing (TILDA). Invest Ophthalmol Vis Sci 53:7855–7861PubMedCrossRef Nolan JM, Feeney J, Kenny RA, Cronin H, O'Regan C, Savva GM, Loughman J, Finucane C, Connolly E, Meagher K, Beatty S (2012) Education is positively associated with macular pigment: the Irish Longitudinal Study on Ageing (TILDA). Invest Ophthalmol Vis Sci 53:7855–7861PubMedCrossRef
24.
Zurück zum Zitat Werner JS, Donnelly SK, Kliegl R (1987) Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vis Res 27:257–268PubMedCrossRef Werner JS, Donnelly SK, Kliegl R (1987) Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vis Res 27:257–268PubMedCrossRef
25.
Zurück zum Zitat Makridaki M, Carden D, Murray IJ (2009) Macular pigment measurement in clinics: controlling the effect of the ageing media. Ophthalmic Physiol Opt 29:338–344PubMedCrossRef Makridaki M, Carden D, Murray IJ (2009) Macular pigment measurement in clinics: controlling the effect of the ageing media. Ophthalmic Physiol Opt 29:338–344PubMedCrossRef
26.
Zurück zum Zitat van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ (2009) A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt 29:127–137PubMedCrossRef van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ (2009) A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt 29:127–137PubMedCrossRef
27.
Zurück zum Zitat Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T (2004) Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci 45:531–538PubMedCrossRef Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T (2004) Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci 45:531–538PubMedCrossRef
28.
Zurück zum Zitat Xu J, Pokorny J, Smith VC (1997) Optical density of the human lens. J Opt Soc Am A Opt Image Sci Vis 14:953–960PubMedCrossRef Xu J, Pokorny J, Smith VC (1997) Optical density of the human lens. J Opt Soc Am A Opt Image Sci Vis 14:953–960PubMedCrossRef
29.
Zurück zum Zitat Nolan JM, Stack J, O' Donovan O, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84:61–74PubMedCrossRef Nolan JM, Stack J, O' Donovan O, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84:61–74PubMedCrossRef
30.
Zurück zum Zitat Hammond BR Jr, Wooten BR, Snodderly DM (1996) Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vis Res 36:3003–3009PubMedCrossRef Hammond BR Jr, Wooten BR, Snodderly DM (1996) Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vis Res 36:3003–3009PubMedCrossRef
31.
Zurück zum Zitat Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347PubMedCrossRef Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347PubMedCrossRef
32.
Zurück zum Zitat Hammond BR Jr, Fuld K, Snodderly DM (1996) Iris color and macular pigment optical density. Exp Eye Res 62:293–297PubMedCrossRef Hammond BR Jr, Fuld K, Snodderly DM (1996) Iris color and macular pigment optical density. Exp Eye Res 62:293–297PubMedCrossRef
33.
Zurück zum Zitat Wolf-Schnurrbusch UE, Roosli N, Weyermann E, Heldner MR, Hohne K, Wolf S (2007) Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci 48:3783–3787PubMedCrossRef Wolf-Schnurrbusch UE, Roosli N, Weyermann E, Heldner MR, Hohne K, Wolf S (2007) Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci 48:3783–3787PubMedCrossRef
34.
Zurück zum Zitat Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J (2002) A portable instrument for measuring macular pigment with central fixation. Curr Eye Res 25:37–47PubMedCrossRef Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J (2002) A portable instrument for measuring macular pigment with central fixation. Curr Eye Res 25:37–47PubMedCrossRef
35.
Zurück zum Zitat Klein R, Klein BE, Linton KL, DeMets DL (1993) The Beaver Dam eye study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137:190–200PubMed Klein R, Klein BE, Linton KL, DeMets DL (1993) The Beaver Dam eye study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137:190–200PubMed
36.
Zurück zum Zitat Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J (2010) Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Invest Ophthalmol Vis Sci 51:5840–5845PubMedCrossRef Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J (2010) Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Invest Ophthalmol Vis Sci 51:5840–5845PubMedCrossRef
Metadaten
Titel
Macular pigment in ophthalmic practice; a survey
verfasst von
Ian J. Murray
Batul Hassanali
David Carden
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-013-2430-4

Weitere Artikel der Ausgabe 10/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.